02.2024

Orbit Genomics, a Ventac Partners portfolio company, has been selected for the inaugural cohort of startups of the CancerX Accelerator program. For more information: https://orbitgenomics.com/2024/02/26/orbit-genomics-has-been-selected-for-the-inaugural-cohort-of-startups-in-cancerxs-accelerator-program/